Back to results
US 8,895,571 B2Granted
Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
AssigneeIncyte Corporation
InventorsTaisheng Huang, Hao Feng, Lingquan Kong, Anlai Wang, Hai Fen Ye, Chu-Biao Xue
Life of this patent
Estimating the term…
Abstract
The present invention provides isoindolinone and pyrrolopyridinone derivatives, as well as their compositions and methods of use, that inhibit the activity of the serine/threonine kinase, Akt, and are useful in the treatment of diseases related to the activity of Akt including, for example, cancer and other diseases.
Claims35
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- X is N or CR4;
- Y is N or CR5;
- Z is N or CR6, provided at least one of X, Y, and Z comprises a carbon atom;
- A is C6-10 aryl, 5-10 membered heteroaryl, or C3-7 cycloalkyl, wherein said C6-10 aryl, 5-10 membered heteroaryl, and C3-7 cycloalkyl are each optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from Q;
- R1 is H, F, Cl, Br, CN, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, or 5-10 membered heteroaryl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, and 5-10 membered heteroaryl are each optionally substituted with 1, 2, or 3 substituents independently selected from Cy, halo, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, CN, ORa, SRa, C(O)Rb, C(O)NRcRd, C(O)ORa, OC(O)Rb, OC(O)NRcRd, NRcRd, NRc(O)Rb, NRcC(O)NRcRd, NRcC(O)ORa, C(═NRg)NRcRd, NRcC(═NRg)NRcRd, S(O)Rb, S(O)NRcRd, S(O)2Rb, NRcS(O)2Rb, and S(O)2NRcRd, wherein no more than one of said 1, 2, or 3 substituents is Cy;
- R2 is H, C1-6 alkyl, C3-6 cycloalkyl, or 4-6 membered heterocycloalkyl, wherein said 4-6 membered heterocycloalkyl is optionally substituted by 1, 2, or 3 substituents independently selected from RA;
- R3 is H or C1-3 alkyl;
- or R2 and R3 together with the nitrogen atom to which they are both attached form a 4-6 membered heterocycloalkyl group optionally substituted by 1 or 2 substituents independently selected from RA;
- R4 is H, F, Cl, CN, or C1-3 alkyl;
- R5 is H, F, Cl, CN, or C1-3 alkyl;
- R6 is H, F, Cl, CN, or C1-3 alkyl;
- R7 is C1-3 alkyl;
- Q is independently selected from Cy1, -L-Cy1, halo, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, CN, NO2, ORa1, SRa1, C(O)Rb1, C(O)NRc1Rd1, C(O)ORa1, OC(O)Rb1, OC(O)NRc1Rd1, NRc1Rd1, NRc1C(O)Rb1, NRc1C(O)NRc1Rd1, NRc1C(O)ORa1, C(═NRg)NRc1Rd1, NRc1C(═NRg)NRc1Rd1, S(O)Rb1, S(O)NRc1Rd1, S(O)2Rb1, NRc1S(O)2Rb1, and S(O)2NRc1Rd1;
- wherein no more than two Q are independently selected from Cy1 and -L-Cy1, and wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C1-6 haloalkyl, are each optionally substituted by 1, 2, 3, 4 or 5 substituents independently selected from halo, CN, NO2, ORa1, SRa1, C(O)Rb1, C(O)NRc1Rd1, C(O)ORa1, OC(O)Rb1, OC(O)NRc1Rd1, NRc1Rd1, NRc1C(O)Rb1, NRc1C(O)NRc1Rd1, NRc1C(O)ORa1, C(═NRg)NRc1Rd1, NRc1C(═NRg)NRc1Rd1, S(O)Rb1, S(O)NRc1Rd1, S(O)2Rb1, NRc1S(O)2Rb1, and S(O)2NRc1Rd1;
- L is C1-3 alkylene, (C1-3 alkylene)pO(C1-3 alkylene)q, (C1-3 alkylene)pS(C1-3 alkylene)q, (C1-3 alkylene)pC(O)(C1-3 alkylene)q, (C1-3 alkylene)pC(O)NRe(C1-3 alkylene)q, (C1-3 alkylene)pC(O)O(C1-3 alkylene)q, (C1-3 alkylene)pOC(O)(C1-3 alkylene)q, (C1-3 alkylene)pOC(O)NRe(C1-3 alkylene)q, (C1-3 alkylene)pNRe(C1-3 alkylene)q, (C1-3 alkylene)pNReC(O)NRf(C1-3 alkylene)q, (C1-3 alkylene)pS(O)(C1-3 alkylene)q, (C1-3 alkylene)pS(O)NRe(C1-3 alkylene)q, (C1-3 alkylene)pS(O)2(C1-3 alkylene)q, or (C1-3 alkylene)pS(O)2NRe(C1-3 alkylene)q, wherein said C1-3 alkylene occurring in any of the options for L is optionally substituted with 1, 2, or 3 substituents independently selected from F, Cl, CN, NH2, NH(C1-3 alkyl) and N(C1-3 alkyl)2;
- Cy is C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, or 5-10 membered heteroaryl, wherein said C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, and 5-10 membered heteroaryl are each optionally substituted by 1, 2, or 3 substituents independently selected from Cy2 and RB, wherein no more than one of said 1, 2, or 3 substituents is Cy2;
- Cy1 is C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, or 5-6 membered heteroaryl, wherein said C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, and 5-6 membered heteroaryl are each optionally substituted with 1, 2, or 3 substituents independently selected from RC;
- Cy2 is C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, or 5-6 membered heteroaryl, wherein said C3-6 cycloalkyl, C6-10 aryl, 4-6 membered heterocycloalkyl, and 5-6 membered heteroaryl are each optionally substituted with 1, 2, or 3 substituents independently selected from RD;
- RA, RB, RC, and RD are each independently selected from halo, CN, C1-3 alkyl, C1-3 haloalkyl, NO2, ORa2, C(O)Rb2, C(O)NRc2Rd2, C(O)ORa2, OC(O)Rb2, NRc1Rdl, NRc2C(O)Rb2, NRc2C(O)NRc2Rd2, NRc2C(O)ORa2, S(O)2Rb2, NRc2S(O)2Rb2, and S(O)2NRc2Rd2;
- Ra, Rb, Rc, Rd, Ra1, Rb1, Rc1, and Rd1 are each independently selected from H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C6-10 aryl, C3-7 cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C6-10 aryl-C1-3 alkyl, 5-10 membered heteroaryl-C1-3 alkyl, C3-7 cycloalkyl-C1-3 alkyl, and 4-10 membered heterocycloalkyl-C1-3 alkyl, wherein said C6-10 aryl-C1-3 alkyl, 5-10 membered heteroaryl-C1-3 alkyl, C3-7 cycloalkyl-C1-3 alkyl, and 4-10 membered heterocycloalkyl-C1-3 alkyl are each optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from C1-6 alkyl, halo, CN, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(═NRg)NRc3Rd3, NRc3C(═NRg)NRc3Rd3, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3, and S(O)2NRc3Rd3;
- or Rc and Rd together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group or 5-membered heteroaryl group, each optionally substituted with 1, 2, or 3 substituents independently selected from C1-6 alkyl, halo, CN, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(═NRg)NRc3Rd3, NRc3C(═NRg)NRc3Rd3, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3, and S(O)2NRc3Rd3;
- or Rc1 and Rd1 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group or 5-membered heteroaryl group, each optionally substituted with 1, 2, or 3 substituents independently selected from C1-6 alkyl, halo, CN, ORa3, SRa3, C(O)Rb3, C(O)NRc3Rd3, C(O)ORa3, OC(O)Rb3, OC(O)NRc3Rd3, NRc3Rd3, NRc3C(O)Rb3, NRc3C(O)NRc3Rd3, NRc3C(O)ORa3, C(═NRg)NRc3Rd3, NRc3C(═NRg)NRc3Rd3, S(O)Rb3, S(O)NRc3Rd3, S(O)2Rb3, NRc3S(O)2Rb3, and S(O)2NRc3Rd3;
- Ra2, Rb2, Rc2, and Rd2 are each independently selected from H, C1-3 alkyl, and C3-6 cycloalkyl;
- or Rc2 and Rd2 together with the N atom to which they are attached form a 4-, 5-, or 6-membered heterocycloalkyl group or 5-membered heteroaryl group;
- Ra3, Rb3, Rc3, and Rd3 are each independently selected from H, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, C6-10 aryl-C1-3 alkyl, 5-10 membered heteroaryl-C1-3 alkyl, C3-7 cycloalkyl-C1-3 alkyl, and 4-10 membered heterocycloalkyl-C1-3 alkyl, wherein said C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl C6-10 aryl-C1-3 alkyl, 5-10 membered heteroaryl-C1-3 alkyl, C3-7 cycloalkyl-C1-3 alkyl, and 4-10 membered heterocycloalkyl-C1-3 alkyl are each optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, and C1-6 haloalkoxy;
- or Rc3 and Rd3 together with the N atom to which they are attached form a 4-, 5-, 6- or 7-membered heterocycloalkyl group or 5-membered heteroaryl group, each optionally substituted with 1, 2, or 3 substituents independently selected from OH, CN, amino, halo, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, and C1-6 haloalkoxy;
- Re and Rf are each independently selected from H and C1-4 alkyl;
- Rg is H, CN, or NO2;
- n is 0 or 1;
- p is 0 or 1;
- and
- q is 0 or 1.
30 more elements
Dependencies are inferred from the claim text.